“… 2 , 3 ) In contrast, significant AS notably reduced hemoglobin and haptoglobin levels and increased LDH levels, 5 ) indicating that AS also potentially causes hemolysis. 1 , 5 ) Second, the patient had symptomatic severe AS requiring re-AVR, of which staged stent grafting following implantation of the EvolutR valve, which was the only approved valve for valve-in-valve in Japan at that time, could not be performed because the high frame of the EvolutR valve would interfere with the proximal landing zone. Therefore, we considered it reasonable to perform simultaneous intervention for prosthetic valve deterioration and ascending flap to treat both the congestive heart failure and possible causes of the hemolysis.…”